James P Daubert

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients
    James P Daubert
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Am Coll Cardiol 47:98-107. 2006
  2. ncbi request reprint Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged?
    James P Daubert
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Am J Geriatr Cardiol 15:88-92. 2006
  3. ncbi request reprint Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome
    James P Daubert
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Am Heart J 153:53-8. 2007
  4. doi request reprint Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact
    James P Daubert
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    J Am Coll Cardiol 51:1357-65. 2008
  5. ncbi request reprint Performance of a new cardiac cryoablation system in the treatment of cavotricuspid valve isthmus-dependent atrial flutter
    James P Daubert
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642 8679, USA
    Pacing Clin Electrophysiol 28:S142-5. 2005
  6. ncbi request reprint Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy
    David T Huang
    Cardiology Unit, The Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    J Cardiovasc Electrophysiol 18:833-8. 2007
  7. doi request reprint Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)
    Mehmet K Aktas
    University of Rochester Medical Center, Rochester, New York 14642, USA
    Heart Rhythm 10:193-9. 2013
  8. pmc Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators
    Saadia Sherazi
    Department of Medicine, Unity Health System, Rochester, NY 14626, USA
    Cardiol J 17:267-73. 2010
  9. doi request reprint Cardiac-resynchronization therapy for the prevention of heart-failure events
    Arthur J Moss
    Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    N Engl J Med 361:1329-38. 2009
  10. doi request reprint Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy
    James P Daubert
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Pacing Clin Electrophysiol 32:755-61. 2009

Detail Information

Publications56

  1. ncbi request reprint Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients
    James P Daubert
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Am Coll Cardiol 47:98-107. 2006
    ..However, ICD therapy for spontaneous VF was less common at two years in inducible patients (3.2%) than in noninducible patients (8.6%). In the MADIT II study, inducibility predicted an increased likelihood of VT but decreased VF...
  2. ncbi request reprint Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged?
    James P Daubert
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Am J Geriatr Cardiol 15:88-92. 2006
    ..Subset analysis seems to support ICD implantation in a highly select elderly subgroup, but a prospective randomized trial may be warranted...
  3. ncbi request reprint Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome
    James P Daubert
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Am Heart J 153:53-8. 2007
    ..1980;303:322-4) as a treatment to prevent sudden cardiac death. Consequently, implanted cardioverter-defibrillator therapy deserves serious consideration as an important therapy for LQTS...
  4. doi request reprint Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact
    James P Daubert
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    J Am Coll Cardiol 51:1357-65. 2008
    ..This study sought to identify the incidence and outcome related to inappropriate implantable cardioverter-defibrillator (ICD) shocks, that is, those for nonventricular arrhythmias...
  5. ncbi request reprint Performance of a new cardiac cryoablation system in the treatment of cavotricuspid valve isthmus-dependent atrial flutter
    James P Daubert
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642 8679, USA
    Pacing Clin Electrophysiol 28:S142-5. 2005
    ..Cryoablation is a promising new treatment of CTI-dependent AFL refractory to medical therapy. Further improvements in catheter design and intravascular sheaths will be tested in a larger multicenter trial...
  6. ncbi request reprint Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy
    David T Huang
    Cardiology Unit, The Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    J Cardiovasc Electrophysiol 18:833-8. 2007
    ..Effective primary prevention of sudden cardiac death with implantable cardioverter defibrillators is well demonstrated in patients with coronary disease and depressed ventricular function...
  7. doi request reprint Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)
    Mehmet K Aktas
    University of Rochester Medical Center, Rochester, New York 14642, USA
    Heart Rhythm 10:193-9. 2013
    ..Defibrillation threshold (DFT) testing is commonly practiced at the time of implantable cardioverter-defibrillator (ICD) implant. The clinical consequence of ICD shocks delivered during DFT testing is unknown...
  8. pmc Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators
    Saadia Sherazi
    Department of Medicine, Unity Health System, Rochester, NY 14626, USA
    Cardiol J 17:267-73. 2010
    ..Information is limited regarding the knowledge and attitudes of physicians typically involved in the referral of patients for implantable cardioverter-defibrillator (ICD) implantation...
  9. doi request reprint Cardiac-resynchronization therapy for the prevention of heart-failure events
    Arthur J Moss
    Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    N Engl J Med 361:1329-38. 2009
    ....
  10. doi request reprint Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy
    James P Daubert
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA
    Pacing Clin Electrophysiol 32:755-61. 2009
    ....
  11. ncbi request reprint Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator
    Arthur J Moss
    Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Circulation 110:3760-5. 2004
    ..This analysis from the MADIT-II trial database examines the long-term clinical course and subsequent mortality risk of patients after termination of life-threatening ventricular tachyarrhythmias by an ICD...
  12. ncbi request reprint Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy
    Henry W Sesselberg
    Department of Medicine, Cardiology Unit, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Heart Rhythm 4:1395-402. 2007
    ..Much of prognostic implications of ventricular arrhythmia storms remain unclear...
  13. doi request reprint Reduction in inappropriate therapy and mortality through ICD programming
    Arthur J Moss
    Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642 0653, USA
    N Engl J Med 367:2275-83. 2012
    ..The implantable cardioverter-defibrillator (ICD) is highly effective in reducing mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are frequent, with potential adverse effects...
  14. ncbi request reprint Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol
    Arthur J Moss
    Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Ann Noninvasive Electrocardiol 10:34-43. 2005
    ..30), and prolonged intraventricular conduction (QRS duration>or=130 ms)...
  15. doi request reprint Effect of biventricular pacing during a ventricular sensed event
    Mehmet Kemal Aktas
    Cardiology Department, University of Rochester Medical Center, Rochester, New York, USA
    Am J Cardiol 103:1741-5. 2009
    ....
  16. doi request reprint Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT
    Alon Barsheshet
    Cardiology Division, Heart Research Follow Up Program, University of Rochester Medical Center, Rochester, NY, USA
    Eur Heart J 32:1622-30. 2011
    ..We evaluated the outcome of patients enrolled in MADIT-CRT by ischaemic and non-ischaemic aetiology of cardiomyopathy (ICM and non-ICM, respectively)...
  17. ncbi request reprint Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    Arthur J Moss
    Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA
    N Engl J Med 346:877-83. 2002
    ..This randomized trial was designed to evaluate the effect of an implantable defibrillator on survival in such patients...
  18. pmc Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)
    Ritesh Dhar
    Institute for Clinical Research and Health Policy Studies, Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
    Heart Rhythm 5:807-13. 2008
    ..There is conflicting literature on the relationship between prolonged QRS duration (QRSd) and arrhythmic events, including sudden cardiac death (SCD), in heart failure patients with or without implantable cardioverter-defibrillators (ICDs)...
  19. ncbi request reprint Congenital long QT syndrome: considerations for primary care physicians
    Ethan Levine
    Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642 8679, USA
    Cleve Clin J Med 75:591-600. 2008
    ..We can now classify some types of congenital long QT syndrome according to their genetic mutations and their triggers, such as exercise, rest, or startle...
  20. ncbi request reprint Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation
    Wojciech Zareba
    Cardiology Unit, Department of Medicine, University of Rochester Medical Center, New York 14642, USA
    Heart Rhythm 3:631-7. 2006
    ..Atrial fibrillation (AF) contributes to increased risk of morbidity and mortality. Data regarding the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in AF patients are limited...
  21. doi request reprint Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators
    Ryan Anthony
    Department of Medicine, Case Western Reserve University University Hospitals Case Medical Center, Cleveland, Ohio, USA
    Pacing Clin Electrophysiol 31:144-50. 2008
    ....
  22. doi request reprint Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)
    Wojciech Zareba
    Cardiology Division, University of Rochester, Rochester, NY, USA
    Circulation 123:1061-72. 2011
    ....
  23. ncbi request reprint Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Kenneth A Ellenbogen
    Department of Medicine, Medical College of Virginia, Richmond, VA 23298 0053, USA
    Circulation 113:776-82. 2006
    ..The practice of equating ICD shocks with mortality is controversial and has not been validated critically...
  24. ncbi request reprint Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators
    Ilan Goldenberg
    Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Cardiovasc Electrophysiol 17:931-6. 2006
    ..Nicotine elevates serum catecholamine concentration and is therefore potentially arrhythmogenic. However, the effect of cigarette smoking on arrhythmic risk in coronary heart disease patients is not well established...
  25. doi request reprint Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies
    Mehmet K Aktas
    Department of Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, New York, USA
    Pacing Clin Electrophysiol 32:1501-8. 2009
    ..The influence of right ventricular (RV) function on ICD therapy for sudden cardiac death (SCD) is not known...
  26. doi request reprint Acute and long-term efficacy and safety of catheter cryoablation of the cavotricuspid isthmus for treatment of type 1 atrial flutter
    Gregory K Feld
    Department of Medicine, Division of Cardiology, University of California, San Diego, California 92103, USA
    Heart Rhythm 5:1009-14. 2008
    ..Atrial flutter (AFL) is commonly treated by radiofrequency catheter ablation. Catheter-based cryoablation may be an effective alternative with potential advantages...
  27. doi request reprint Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: results from the Duke Databank for Cardiovascular Disease (DDCD)
    Eric S Williams
    Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Am Heart J 164:434-41. 2012
    ..In several studies, prolongation of the corrected QT (QTc) interval has been associated with an increased risk of cardiac events. However, data on race and gender variation in the QTc and its associated risk of death are lacking...
  28. ncbi request reprint Catheter ablation of atrial fibrillation in the elderly: where do we stand?
    Darren Traub
    Cardiology Division, University of Rochester Medical Center, Rochester, NY 14642, USA
    Cardiol J 16:113-20. 2009
    ....
  29. doi request reprint Risks and challenges of implantable cardioverter-defibrillators in young adults
    Mark V Sherrid
    Cardiology Division, Department of Medicine, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York City, NY 10019, USA
    Prog Cardiovasc Dis 51:237-63. 2008
    ..Although devices may prolong life, they come with problems that will pose unique challenges for both patients and their physicians. Moreover, because of the long durations, these problems may accelerate as patients age...
  30. ncbi request reprint Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial
    Arthur J Moss
    Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Ann Noninvasive Electrocardiol 10:59-66. 2005
    ..In vitro studies have shown that flecainide provides correction of the impaired inactivation associated with the DeltaKPQ deletion...
  31. ncbi request reprint Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
    Alan Kadish
    Clinical Cardiology Trials Office, Division of Cardiology, Department of Medicine, Northwestern University Medical School, Chicago, USA
    N Engl J Med 350:2151-8. 2004
    ..However, the value of prophylactic implantation of an implantable cardioverter-defibrillator (ICD) to prevent sudden death in such patients is unknown...
  32. ncbi request reprint Implantable cardioverter defibrillator in high-risk long QT syndrome patients
    Wojciech Zareba
    Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642 8653, USA
    J Cardiovasc Electrophysiol 14:337-41. 2003
    ..There was 1 (1.3%) death in 73 ICD patients followed an average of 3 years, whereas there were 26 deaths (16%) in non-ICD patients during mean 8-year follow-up (P = 0.07 from log rank test from Kaplan-Meier curves)...
  33. doi request reprint Predictive capability of left atrial size measured by CT, TEE, and TTE for recurrence of atrial fibrillation following radiofrequency catheter ablation
    Sachin S Parikh
    Division of Cardiology, University of Rochester Medical Center, Rochester, New York 14642, USA
    Pacing Clin Electrophysiol 33:532-40. 2010
    ..The purpose of this study was to assess the predictive capability of LA diameter (LAD) and LA volume (LAV) by echocardiography and computed tomography (CT) to determine success in patients undergoing RFCA of AF...
  34. ncbi request reprint Temporal complexity of repolarization and mortality in patients with implantable cardioverter defibrillators
    Juha S Perkiomaki
    Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Pacing Clin Electrophysiol 26:1931-6. 2003
    ..None of the repolarization variability parameters independently predicted death/appropriate ICD shocks. Increased temporal complexity of repolarization (RTmax-ApEn) independently predicts mortality in ICD patients...
  35. doi request reprint Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy
    Mark V Sherrid
    St Luke s Roosevelt Hospital Center, Columbia University, New York, NY, USA
    Am J Cardiol 104:1722-6. 2009
    ....
  36. doi request reprint Clinical predictors of survival in patients treated with therapeutic hypothermia following cardiac arrest
    Alian Aguila
    University of Rochester Medical Center, Department of Cardiovascular Diseases, Rochester, NY, United States
    Resuscitation 81:1621-6. 2010
    ..We report outcomes of consecutive patients receiving therapeutic hypothermia for cardiac arrest and describe predictors of short and long-term survival...
  37. doi request reprint Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator
    Saadia Sherazi
    Department of Community and Preventive Medicine, University of Rochester Medical Center, PO Box 644, 601 Elmwood Ave, Rochester, NY 14642, USA
    Mayo Clin Proc 83:1139-41. 2008
    ..With increased knowledge about managing the withdrawal of this potentially life-prolonging therapy, physicians are likely to become more skilled at caring for dying patients with an ICD...
  38. ncbi request reprint Update on implantable cardioverter defibrillator trials
    Abrar H Shah
    Department of Medicine, Box 679 Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Curr Cardiol Rep 6:327-32. 2004
    ..In these trials, predictors of sudden or total mortality better than ventricular dysfunction have not emerged. This review summarizes the randomized ICDs trials and the impact ICDs have on SCD prevention...
  39. doi request reprint Direct His bundle pacing post AVN ablation
    Umashankar Lakshmanadoss
    Unity Health System, Rochester, New York 14626, USA
    Pacing Clin Electrophysiol 32:1101-4. 2009
    ..Here, we present a case of direct His bundle pacing using steerable lead delivery system in a patient with symptomatic paroxysmal AF with concurrent AVN ablation...
  40. ncbi request reprint Surgical atrial fibrillation ablation: a review of contemporary techniques and energy sources
    Mehmet K Aktas
    University of Rochester, Strong Memorial Hospital, Department of Cardiovascular Diseases, Rochester, New York 14642, USA
    Cardiol J 15:87-94. 2008
  41. ncbi request reprint Venous thrombosis and stenosis after implantation of pacemakers and defibrillators
    Grzegorz Rozmus
    Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Strong Memorial Hospital, 601 Elmwood Ave, Box 679, Rochester, NY, 14642, USA
    J Interv Card Electrophysiol 13:9-19. 2005
    ..Anticoagulant therapy (for other reasons than pacemaker lead) seemed to have protective antithrombotic effect...
  42. doi request reprint Defibrillation coil reversal: a rare cause of abnormal noise and inappropriate shocks
    Vinodh Jeevanantham
    Unity Hospital, Rochester, New York, USA
    Pacing Clin Electrophysiol 31:375-7. 2008
    ....
  43. doi request reprint Catheter ablation of atrial fibrillation in the elderly
    Eric S Williams
    Division of Cardiology, Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina 27710, USA
    Curr Opin Cardiol 26:25-9. 2011
    ..Clinical trials to guide the optimal management strategy in this population are lacking...
  44. doi request reprint Implantable cardioverter defibrillators: risks accompany the life-saving benefits
    Brett D Atwater
    Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, NC 27710, USA
    Heart 98:764-72. 2012
    ..This commentary summarises the weaknesses, disadvantages and risks of the ICD in a balanced fashion in light of their proven life-saving benefits...
  45. ncbi request reprint Moxifloxacin-induced torsades de pointes
    Saadia Sherazi
    Unity Health System, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14626, USA
    Cardiol J 15:71-3. 2008
    ..Although it is difficult to predict which patients are at risk from TdP, careful assessment of the risk/benefit ratio is important before prescribing drugs known to cause QT prolongation...
  46. doi request reprint Identification of a retained intravascular wire by three-dimensional transesophageal echocardiography
    Stephen R Tokarz
    Department of Electrophysiology, University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY 14642, USA
    Echocardiography 26:463-4. 2009
    ..He was referred to our hospital for repeat VT ablation. TEE revealed a wire coiled in the right pulmonary artery. This is the first reported identification of an embolized wire by transesophageal three-dimensional echocardiography...
  47. doi request reprint Impact of using a telescoping-support catheter system for left ventricular lead placement on implant success and procedure time of cardiac resynchronization therapy
    Kevin P Jackson
    Division of Clinical Cardiac Electrophysiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Pacing Clin Electrophysiol 36:553-8. 2013
    ..We sought to evaluate the impact of an LV lead implant approach using telescoping-support catheters (group TS) on success rate, lead location, and procedural time compared to standard over-the-wire implant techniques (group OTW)...
  48. doi request reprint Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?
    Larry R Jackson
    Electrophysiology Section, Cardiology Division, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
    Prog Cardiovasc Dis 54:372-8. 2012
    ....
  49. ncbi request reprint Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)
    Jagmeet P Singh
    Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    J Am Coll Cardiol 46:1712-20. 2005
    ....
  50. ncbi request reprint Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Barry J Maron
    Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA
    JAMA 298:405-12. 2007
    ..However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved...
  51. ncbi request reprint Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program
    Angel R Leon
    Carlyle Fraser Heart Center Division of Cardiology, Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 46:2348-56. 2005
    ..The purpose of this study was to evaluate the safety of implanting a cardiac resynchronization therapy (CRT) system...
  52. ncbi request reprint Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)
    William N Brodine
    Research Medical Center and Kansas City Heart Foundation, Kansas City, Missouri, USA
    Am J Cardiol 96:691-5. 2005
    ..42 to 0.44, p <0.01). In conclusion, beta blockers reduce the risk for VT or VF and improve survival in ICD-treated patients with ischemic cardiomyopathy...
  53. doi request reprint Time dependence of arrhythmias in ICD patients
    Brett Faulknier
    J Cardiovasc Electrophysiol 19:790-3. 2008
  54. ncbi request reprint Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure
    Angel R Leon
    Carlyle Fraser Heart Center Division of Cardiology, Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 46:2298-304. 2005
    ..The InSync III study evaluated sequential cardiac resynchronization therapy (CRT) in patients with moderate-to-severe heart failure and prolonged QRS...
  55. ncbi request reprint Iatrogenic left atrial tachycardias: where are we?
    James P Daubert
    J Am Coll Cardiol 50:1788-90. 2007
  56. doi request reprint Mystery of biphasic defibrillation waveform efficacy is it calcium?
    James P Daubert
    J Am Coll Cardiol 52:836-8. 2008